In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

Naval theorist Alfred Thayer Mahan would likely be baffled by Trump’s war on drugs—but would be instantly familiar with his ...

Sinaptica Therapeutics Completes Scientific Advisory Board, Bringing Together Leading Voices Across Patients, Science, ...

Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus ...

William Carey University (WCU) will begin offering a Ph.D. in Neurodiverse Studies in January. The program is the first and ...

How a Bren School PhD fellow helps high school students shift from focusing on the what, toward a deeper interest in the how.

Newer therapies improve inflammatory rosacea, yet additional research is needed to help clinicians manage vascular, ...

The Vietnam National University, Ho Chi Minh City (VNU-HCM) aims to enter the top 100 higher education institutions in Asia ...

RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and 60 Degrees Pharmaceuticals, Inc. ...

Framing the environment as a silent victim suggests its passivity during armed conflicts. But the ecological consequences of ...

Since its discovery, Alzheimer's disease has been considered irreversible. Consequently, research has focused on preventing ...

Manufacturers use AI and sensors to optimize post-consumer resin processing and improve quality control in plastics ...